Advertisement
Advertisement

ARGX

ARGX logo

Argen X SE - ADR

624.16
USD
+0.34
+0.06%
Dec 23, 14:32 UTC -5
Open

Argen X SE - ADR Profile

About

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

Info & Links

CEO

Tim Van Hauwermeiren

Headquarters

LAARDERHOOGTWEG 25
AMSTERDAM, P7 1101EB, NETHERLANDS

Auditor

Deloitte Accountants B.V.

Share holders

1

Employees

1,148

Argen X SE - ADR Statistics

Valuation Measures

Market Capitalization2

37.68B

Enterprise Value

37.68B

Enterprise Value/EBITDA(ttm)

-221.94

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

19.80

Price to Book(mrq)

8.78

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

90.46%

Operating Margin(ttm)

-2.11%

Profit Margin(ttm)

-3.71%

Return on Equity(ttm)

-1.45%

Return on Invested Capital(ttm)

-1.74%

Return on Assets(ttm)

-1.29%

Income Statement

Revenue(ttm)

1.50B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

1.35B

EBITDA(ttm)3

-169.78M

Net Income Available to Common(ttm)

21.30M

Diluted EPS(ttm)

-0.88

Share Statistics

Beta (5Y Monthly)

0.59

52-Week Change

36.36%

S&P 500 52-Week Change

24.91%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

58.90M

% Held by Insiders

2.43%

% Held by Institutions

60.32%

Balance Sheet

Total Cash(mrq)

0.00

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

7.88%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement